![]() |
|
|
Forward to a colleague |
||
Access Full Stories Illumina's third quarter revenues soared 82 per cent while Affymetrix looked to bolster its slice of the genetics market by filing more patent infringement claims against the young pretender... Read BioSPM drives JPK into 'Technology Fast 50' Scanning probe microscope (SPM) maker, JPK Instruments has been named as Germany's fastest growing nanotechnology company in accounting firm Deloitte's 'Technology Fast 50'... Read Sigma-Aldrich set to break $2bn yearly sales barrier Sigma-Aldrich continued its strong year with both revenues and pre-tax profits showing strong double-digit growth in the third quarter predicting it will break the $2bn (€1.4bn) revenue mark this year... Read Strong demand causes Waters Q3 to rise Broad-based sales growth has helped push Waters third quarter revenues up 17 per cent to $353m (€248m) compared with the same period last year... Read Product news in brief - week 43 LabTechnologist.com brings you a round up of recent product news from Arrayjet, Aspectrics, BioTool, Cerno, IDBS, Olympus, Servocell, Tecan, Thermo Fisher Scientific, Viscotek and Warner Instruments... Read |
|||||||||||||||||
All News Headlines for: October | September | August |
|||||||||||||||||
![]() Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here | |||||||||||||||||
|
Related Industry News Sanofi slammed by FDA over failure to act on Ketek fraud The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm... Read J&J, Galapagos sign deal to search for arthritis 'Holy Grail' Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme... Read Microfluidic stimulation of cells in culture US researchers have developed a fully automated microfluidic cell culture system that can control signalling agents in the extracellular media while maintaining cell viability for weeks... Read Pfizer not alone in feeling the heat of California fires As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities... Read
|
|||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||